Top 50 Opportunities for Generic Pharmaceutical Companies Assessed in…

New research study “Prioritizing Generic Drug development pipeline – The top Fifty Opportunities” developed by MP Advisors has been recently published by Market Publishers Ltd.

(PRWeb August 20, 2012)

Read the full story at

Click here for reuse options!
Copyright 2012 Biotechblog

Comments are closed.

%d bloggers like this: